Solid Biosciences SLDB 深 沪
已收盘 09-18 16:00:00 美东时间
7.14
-0.240
-3.25%
华盛通- 最 高7.64
- 今 开7.39
- 成交量 34.93万股
- 最 低 7.09
- 昨 收 7.38
- 总市值 1.43亿
- 52周最高 15.05
- 市盈率 静 --
- 换手率 1.74%
- 52周最低 1.81
- 委 比 -91.39%
- 总股本 2006.00万
- 历史最高 822.60
- 量 比 1.26
- 振 幅 7.45%
- 历史最低 1.81
- 每 手 1
- 风险率 3.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around...
09-16 20:44
Dyne stock tumbles 31% amid drug updates, management changes
Shares of Dyne Therapeutics (NASDAQ:DYN) fell 31% Tuesday after the company released new data from a clinical trial called DELIVER for its drug DYNE-251 in the treatment of Duchenne muscular dystrophy...
09-04 04:48
快讯 | Solid Biosciences Inc：Chardan资本市场将目标价从6美元上调至15美元。
Solid Biosciences Inc : Chardan Capital Markets Raises Target Price to $15 From...
08-19 13:14
Solid Biosciences Q2 EPS $(0.61) Beats $(0.67) Estimate
Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.67) by 8.96 percent. This is a 51.2 percent increase over losses of $(1.25) per share from
08-14 04:56
快讯 | Solid Biosciences Inc：预计现金储备能维持到2026年。
Solid Biosciences Inc: Anticipated Cash Runway Into 2026
08-14 04:18
快讯 | solid biosciences第二季度净利润美元指数-2510万
Solid Biosciences Q2 Net Income USD -25.1 Million
08-14 04:08
快讯 | Solid biosciences报告2024年第二季度财务业绩并提供业务更新。
Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Bu...
08-14 04:08
PepGen stock tumbles 25% following release of DMD drug data
PepGen (NASDAQ:PEPG) stock plunged 25% in post-market trading Tuesday after the company released data for its drug PGN-EDO51 in the treatment of Duchenne muscular dystrophy, or DMD. PepGen reported da...
07-31 07:37
Solid Biosciences’ SGT-003: A Promising Leap in DMD Therapy with Cardiac Safety Superiority
Analyst David Hoang from Citi maintained a Buy rating on Solid Biosciences (SLD...
07-18 08:36
快讯 | Solid Biosciences Inc: Leerink Partners将目标价从12美元提高至28美元。
Solid Biosciences Inc : Leerink Partners Raises Target Price to $28 From $12
07-16 11:04
